| Upcoming events on BAUSCH HEALTH COMPANIES INC. |
|
| 08/10/21 | | Interim 2021 Earnings Release (Projected) |
| 11/09/21 | | Q3 2021 Earnings Release (Projected) |
| 02/23/22 | | FY 2021 Earnings Release (Projected) |
| 05/10/22 | | Q1 2022 Earnings Release (Projected) |
|
| Past events on BAUSCH HEALTH COMPANIES INC. |
|
| 06/02/21 | 11:00am | | Jefferies Healthcare Conference |
| 05/25/21 | 12:45pm | | Barclays High Yield Bond & Syndicated Loan Conference |
| 05/21/21 | | Digestive Disease Week Conference |
| 05/17/21 | 01:10pm | | Goldman Sachs Leveraged Finance Conference |
|
|
|
| Annual results | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (e) |
Sales
M $ |
Released
Forecast
Spread | 9 674
9 605
0,72% | 8 724
8 741
-0,19% | 8 380
8 330
0,60% | 8 601
8 572
0,34% | 8 027
7 968
0,74% |
8 611
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 4 305
4 266
0,92% | 3 638
3 623
0,42% | 3 474
3 416
1,7% | 3 571
3 585
-0,38% | 3 294
3 257
1,1% |
3 450
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 4 013
3 987
0,65% | 3 277
3 325
-1,4% | 3 193
3 177
0,51% | 3 226
3 304
-2,4% | 2 959
3 003
-1,5% |
3 137
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -2 435
-2 238
-8,8% | -1 741
-1 219
-43% | -4 154
-4 230
1,8% | -1 837
-423
-334% | -934
-577
-62% |
-679
|
Net income
M $ |
Released
Forecast
Spread | -2 409
-2 151
-12% | 2 404
1 579
52% | -4 148
-4 384
5,4% | -1 788
-333
-436% | -560
-529
-5,9% |
-719
|
EPS
$ |
Released
Forecast
Spread | -6,94
-6,21
-12% | 6,83
4,45
53% | -11,8
-12,4
4,7% | -5,08
-0,97
-422% | -1,58
-1,47
-7,5% |
-1,92
| | Announcement Date | 02/28/2017 | 02/28/2018 | 02/20/2019 | 02/19/2020 | 02/24/2021 | |
|
|
|
| Quarterly results | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) | 2022 Q1 (e) | 2022 Q2 (e) |
Sales
M $ |
Released
Forecast
Spread | 2 121
2 080
2,0% | 2 016
2 029
-0,62% | 2 152
2 151
0,05% | 2 209
2 155
2,5% | 2 224
2 197
1,2% | 2 012
2 030
-0,89% | 1 664
1 785
-6,8% | 2 138
2 049
4,4% | 2 213
2 175
1,8% | 2 027
2 061
-1,6% |
2 115
|
2 186
|
2 275
|
2 177
|
2 238
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 858
824
4,1% | 851
819
3,9% | 880
894
-1,5% | 942
890
5,9% | 898
913
-1,6% | 813
802
1,3% | 622
730
-15% | 948
847
12% | 911
880
3,6% | 852
817
4,3% |
803
|
873
|
921
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 789
774
2,0% | 775
744
4,2% | 790
821
-3,8% | 854
818
4,4% | 807
846
-4,6% | 754
733
2,9% | 552
649
-15% | 888
777
14% | 813
816
-0,35% | 735
729
0,84% |
754
|
784
|
815
|
731
|
784
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -426
-379
-12% | -122
-414
71% | -179
-145
-23% | -66,0
-73,5
10% | -1 470
-56,1
-2 523% | -178
-123
-45% | -437
-205
-114% | 75,0
-53,9
239% | -394
31,6
-1 345% | -591
-64,0
-824% |
-95,0
|
-87,5
|
-61,5
|
|
|
Net income
M $ |
Released
Forecast
Spread | -344
-436
21% | -52,0
-428
88% | -171
-171
0,02% | -49,0
-90,1
46% | -1 516
-61,4
-2 370% | -152
-159
4,3% | -326
-202
-61% | 71,0
-99,0
172% | -153
-80,0
-91% | -610
-58,4
-944% |
-131
|
-125
|
-103
|
|
|
EPS
$ |
Released
Forecast
Spread | -0,98
-1,23
20% | -0,15
-1,21
88% | -0,49
-0,31
-60% | -0,14
-0,24
43% | -4,30
-0,19
-2 140% | -0,43
-0,38
-12% | -0,92
-0,52
-78% | 0,20
-0,27
174% | -0,43
-0,23
-90% | -1,71
-0,16
-947% |
-0,27
|
-0,21
|
-0,15
|
-0,32
|
-0,29
| | Announcement Date | 02/20/2019 | 05/06/2019 | 08/06/2019 | 11/04/2019 | 02/19/2020 | 05/07/2020 | 08/06/2020 | 11/03/2020 | 02/24/2021 | 05/04/2021 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous period
